Home   >   Resources   >   POG Talks

POG Talks

POG Talks provide a platform for POG members to educate and disseminate research and knowledge to the members of POG, POG's affiliates, and the research community as a whole.

2019

2019
2019
Bozoky, Z.
Accelerate decision making with the support of genomic and health data sharing
2019
Dixon, K.
Molecular mechanisms of cancer susceptibility and implications for genetic diagnosis.
2019
Eirew, P.
Profiling specific sensitivities of patient tumours by in vivo xenograft CRISPR screening.
2019
Lee, M.
Treatment paradigm shift in pancreatic adenocarcinoma with increased genomic profiling.
2019
Pleasance, P.
Pan-cancer analysis of POG tumour landscapes reveals impact of prior therapy.

2018

2018
Grewal, J.
POG Talks
Automated cancer diagnosis: using machine learning to identify the site of origin of metastatic cancers.
2018
Karasinska, J.
Clinical relevance of metabolic plasticity in pancreatic cancer POG Talks.
2018
LeVasseur, N.
Whole genome sequencing in metastatic breast cancer — lessons learned from the BC Cancer Personalized Oncogenomics (POG) program.
2018
Liu, L.
Outcomes of whole genome and transcriptome sequencing (WGTS) in metastatic colorectal cancer (mCRC) and advanced gynecologic malignancies (AGM): results from the Personalized Oncogenomics (POG) program.
2018
Pearson, H.
Genomic biomarkers of response to checkpoint inhibitor immunotherapy in the Personalized OncoGenomics cohort.
2018
Schlosser, C.
Endogenous retroelement-containing transcripts are associated with signatures of immunogenicity in metastatic pancreatic ductal adenocarcinoma.
2018
Thibodeau, M.L.
APOBEC3A/B germline deletion and somatic mutational signatures in diverse cancers.
2018
Topham, J.
Enriching tumour content for better genomics.
2018
Weymann, D.
The economics of applying whole-genome and transcriptome analysis to guide treatment for incurable cancers.
2018
Williamson, L.
Pancreatic Ductal Adenocarcinoma in the Personalized OncoGenomics Cohort.

2017

2017
Alcaide, M.
Ultrasensitive detection and monitoring of circulating tumour DNA in POG patients.
2017
Tessier-Cloutier, B.
Genomic integrative pathology.
2017
Thibault, P.
Profiling the MHC class I immunopeptidome landscape for cancer immunotherapy.
2017
Titmuss, E.
Angiotensin receptor blocker as a potential immunotherapy in colorectal cancer; POG130 case study.
2017
Zhao, E.
How POG advances genomic instability research.